A biotech company has plans to begin offering a new type of treatment for some blood cancers, in Christchuch.

Ferroptosis offers new strategies to combat treatment resistance in digestive tract cancers, enhancing the efficacy of existing therapies.

In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...

Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, published in the...

Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...

Drugs designed to target HER2-positive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial...

Want to prevent glioblastoma? By applying new techniques like CRISPR/Cas9 screens, scientists have identified new targets for treating glioblastoma,...

Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.

BOSTON--(BUSINESS WIRE)--Oct. 31, 2024-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for...

Researcher creates a groundbreaking genetic model for breast cancer, offering new insights and potential advances in personalized treatment...